Year |
Citation |
Score |
2018 |
Geissbühler Y, Vile J, Koren G, Guennec M, Butzkueven H, Tilson H, MacDonald TM, Hellwig K. Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure. Therapeutic Advances in Neurological Disorders. 11: 1756286418804760. PMID 30542374 DOI: 10.1177/1756286418804760 |
0.335 |
|
2015 |
Vannappagari V, Albano JD, Koram N, Tilson H, Scheuerle AE, Napier MD. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 197: 6-10. PMID 26687320 DOI: 10.1016/J.Ejogrb.2015.11.015 |
0.314 |
|
2015 |
Vannappagari V, Koram N, Albano J, Tilson H, Gee C. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 26269220 DOI: 10.1111/1471-0528.13542 |
0.329 |
|
2015 |
Vannappagari V, Koram N, Albano J, Tilson H, Gee C. Abacavir and lamivudine exposures during pregnancy and non-defect adverse pregnancy outcomes: data from the antiretroviral pregnancy registry. Journal of Acquired Immune Deficiency Syndromes (1999). 68: 359-64. PMID 25469525 DOI: 10.1097/Qai.0000000000000465 |
0.33 |
|
2015 |
Kuemmerle-Deschner J, Hoffman H, Hawkins P, Poll Tvd, Walker U, Speziale A, Tilson H. SAT0524 Evaluation of Long-Term Safety and Effectiveness of Canakinumab Therapy in Patients with Cryopyrin-Associated Periodic Syndrome: Results from Beta-Confident Registry Annals of the Rheumatic Diseases. 74: 850-850. DOI: 10.1136/Annrheumdis-2015-Eular.2224 |
0.311 |
|
2013 |
Albano JD, Tilson H. No evidence for increased risk of cleft lip or cleft palate among infants exposed to antiretroviral drugs during pregnancy in the antiretroviral pregnancy registry. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 50: 376-7. PMID 22424135 DOI: 10.1597/11-251 |
0.319 |
|
2012 |
Esker S, Albano J, Uy J, Arikan D, Jimenez-Exposito MJ, Seekins D, Tilson H. Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy. Aids Patient Care and Stds. 26: 307-11. PMID 22404239 DOI: 10.1089/Apc.2011.0444 |
0.328 |
|
2011 |
Huang HY, Andrews E, Jones J, Skovron ML, Tilson H. Pitfalls in meta-analyses on adverse events reported from clinical trials. Pharmacoepidemiology and Drug Safety. 20: 1014-20. PMID 21858897 DOI: 10.1002/Pds.2208 |
0.324 |
|
2010 |
Esker S, Albano J, Tilson H, Uy J, Arikan D, Krantz K, Jiménez-Expósito M, Seekins D. Assessing the risk of birth defects associated with atazanavir exposure in pregnancy Journal of the International Aids Society. 13: 113. DOI: 10.1186/1758-2652-13-S4-P113 |
0.341 |
|
2008 |
Platt R, Madre L, Reynolds R, Tilson H. Active drug safety surveillance: a tool to improve public health. Pharmacoepidemiology and Drug Safety. 17: 1175-82. PMID 18823068 DOI: 10.1002/Pds.1668 |
0.329 |
|
2007 |
Watts DH, Li D, Handelsman E, Tilson H, Paul M, Foca M, Vajaranant M, Diaz C, Tuomala R, Thompson B. Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 299-305. PMID 17159659 DOI: 10.1097/Qai.0B013E31802E2229 |
0.326 |
|
2006 |
Tilson H, Berkowitz B. The public health enterprise: examining our twenty-first-century policy challenges. Health Affairs (Project Hope). 25: 900-10. PMID 16835168 DOI: 10.1377/Hlthaff.25.4.900 |
0.306 |
|
2006 |
Lenaway D, Halverson P, Sotnikov S, Tilson H, Corso L, Millington W. Public health systems research: setting a national agenda. American Journal of Public Health. 96: 410-3. PMID 16449601 DOI: 10.2105/Ajph.2004.046037 |
0.313 |
|
2005 |
Kupersmith J, Sung N, Genel M, Slavkin H, Califf R, Bonow R, Sherwood L, Reame N, Catanese V, Baase C, Feussner J, Dobs A, Tilson H, Reece EA. Creating a new structure for research on health care effectiveness. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 53: 67-72. PMID 15810492 DOI: 10.2310/6650.2005.00204 |
0.336 |
|
2004 |
Watts DH, Covington DL, Beckerman K, Garcia P, Scheuerle A, Dominguez K, Ross B, Sacks S, Chavers S, Tilson H. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy. American Journal of Obstetrics and Gynecology. 191: 985-92. PMID 15467577 DOI: 10.1016/J.Ajog.2004.05.061 |
0.329 |
|
2004 |
Covington DL, Tilson H, Elder J, Doi P. Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry. Pharmacoepidemiology and Drug Safety. 13: 537-45. PMID 15317035 DOI: 10.1002/Pds.982 |
0.355 |
|
2004 |
Cioffi JP, Lichtveld MY, Tilson H. A research agenda for public health workforce development. Journal of Public Health Management and Practice : Jphmp. 10: 186-92. PMID 15253514 DOI: 10.1097/00124784-200405000-00002 |
0.316 |
|
2004 |
Tilson H, Gebbie KM. The public health workforce. Annual Review of Public Health. 25: 341-56. PMID 15015924 DOI: 10.1146/Annurev.Publhealth.25.102802.124357 |
0.317 |
|
2004 |
Crowley WF, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korn A, Reame N, Bonow R, Grebb J, et al. Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. Jama. 291: 1120-6. PMID 14996782 DOI: 10.1001/Jama.291.9.1120 |
0.308 |
|
2003 |
Tilson H, Helms D, Dowdy D. Improving the US health care system: action plan to enhance efficiency, reduce errors, and improve quality. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 51: 72-8. PMID 12643511 DOI: 10.1136/Jim-51-02-08 |
0.301 |
|
2003 |
Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, et al. Central challenges facing the national clinical research enterprise. Jama. 289: 1278-87. PMID 12633190 DOI: 10.1001/Jama.289.10.1278 |
0.313 |
|
2003 |
Beckerman K, Covington D, Watts H, Tilson H, Chavers S, Sacks S. Risk of birth defects associated with antiretroviral exposure during pregnancy American Journal of Obstetrics and Gynecology. 189. DOI: 10.1016/J.Ajog.2003.10.012 |
0.327 |
|
2002 |
Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiology and Drug Safety. 11: 465-75. PMID 12426931 DOI: 10.1002/Pds.726 |
0.322 |
|
2001 |
Lichtveld MY, Cioffi JP, Baker EL, Bailey SB, Gebbie K, Henderson JV, Jones DL, Kurz RS, Margolis S, Miner K, Thielen L, Tilson H. Partnership for front-line success: a call for a national action agenda on workforce development. Journal of Public Health Management and Practice : Jphmp. 7: 1-7. PMID 11434035 DOI: 10.1097/00124784-200107040-00002 |
0.314 |
|
Show low-probability matches. |